Intake Periods (Weeks) | Change (%) | |||
---|---|---|---|---|
0 | 8 | |||
WBC (/μL) | Control | 6060 ± 665 | 5500 ± 619 | 91.4 ± 5.3 |
LAFEW 6 g | 5329 ± 467 | 5214 ± 528 | 98.1 ± 4.3 | |
LAFEW 8 g | 6150 ± 887 | 5900 ± 753 | 97.9 ± 7.8 | |
RBC (/μL) | Control | 498 ± 16 | 493 ± 15 | 99.0 ± 1.0 |
LAFEW 6 g | 501 ± 20 | 491 ± 18 | 98.2 ± 1.8 | |
LAFEW 8 g | 512 ± 7 | 495 ± 7* | 96.6 ± 1.0 | |
Hb (g/dL) | Control | 15.2 ± 0.3 | 15.1 ± 0.4 | 99.1 ± 0.8 |
LAFEW 6 g | 15.4 ± 0.5 | 15.0 ± 0.3 | 97.2 ± 1.9 | |
LAFEW 8 g | 15.7 ± 0.3 | 15.1 ± 0.2* | 96.7 ± 1.1 | |
Ht (%) | Control | 47.4 ± 1.2 | 48.0 ± 1.0 | 101 ± 1.2 |
LAFEW 6 g | 47.7 ± 1.6 | 46.7 ± 1.1 | 98.1 ± 1.9 | |
LAFEW 8 g | 48.8 ± 0.6 | 48.1 ± 0.5 | 98.7 ± 0.7 | |
MCV (fl) | Control | 95.2 ± 1.1 | 97.6 ± 1.5* | 103 ± 0.6 |
LAFEW 6 g | 95.5 ± 2.3 | 95.3 ± 1.8 | 99.9 ± 0.7# | |
LAFEW 8 g | 95.4 ± 0.5 | 97.4 ± 1.1* | 102 ± 0.7 | |
MCH (pg) | Control | 30.6 ± 0.6 | 30.6 ± 0.7 | 100 ± 0.5 |
LAFEW 6 g | 30.9 ± 0.7 | 30.6 ± 0.7 | 98.9 ± 0.6 | |
LAFEW 8 g | 30.6 ± 0.5 | 30.6 ± 0.4 | 100 ± 0.3 | |
MCHC (%) | Control | 32.1 ± 0.3 | 31.4 ± 0.4* | 97.6 ± 0.8 |
LAFEW 6 g | 32.4 ± 0.3 | 32.1 ± 0.2 | 99.1 ± 0.9 | |
LAFEW 8 g | 32.1 ± 0.4 | 31.5 ± 0.3* | 98.1 ± 0.8 | |
Platelet (/μL) | Control | 22.0 ± 2.6 | 22.1 ± 2.5 | 101 ± 4.0 |
LAFEW 6 g | 20.9 ± 2.1 | 21.2 ± 2.0 | 102 ± 5.7 | |
LAFEW 8 g | 23.5 ± 1.4 | 24.9 ± 1.5 | 106 ± 2.6 |